Montelukast in allergic rhinitis: a systematic review and meta-analysis (Q36609797)

15 August 2017

0 references

1 reference

title

Montelukast in allergic rhinitis: a systematic review and meta-analysis (English)

1 reference

15 August 2017

1 reference

1 reference

1 reference

Grainger J

1

1 reference

15 August 2017

Drake-Lee A

series ordinal

2

1 reference

15 August 2017

language of work or name

1 reference

1 October 2006

1 reference

15 August 2017

Clinical Otolaryngology

1 reference

15 August 2017

31

1 reference

15 August 2017

5

1 reference

15 August 2017

360-367

1 reference

Burden of allergic disease in the UK: secondary analyses of national databases

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

The prevalence of allergic rhinitis and nasal symptoms in Nottingham

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Leukotriene-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Combined mediator antagonism for allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Efficacy of montelukast in the treatment of nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Leukotriene receptor antagonists are not as effective as intranasal corticosteroids for managing nighttime symptoms of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Prostaglandins, leukotrienes and perennial rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Heat shock preconditioning and eicosanoid pathways modulate caspase 3-like activity in superficially injured isolated guinea pig gastric mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Comparative Effects of Desloratadine versus Montelukast on Asthma Symptoms and Use of β<sub>2</sub>-Agonists in Patients with Seasonal Allergic Rhinitis and Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

Role of leukotriene inhibitors in the postoperative management of nasal polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

The effects of histamine and leukotriene receptor antagonism on nasal mannitol challenge in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2006.01276.X

10.1111/J.1749-4486.2006.01276.X

21 January 2018

Identifiers

DOI

1 reference

release_2yishmkcnbdhjehbhrcehdrcfe

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2yishmkcnbdhjehbhrcehdrcfe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference